Metal‐catalyzed oxidation of human growth hormone: Modulation by solvent‐induced changes of protein conformation
Metal‐catalyzed oxidation (MCO) represents a prominent pathway of protein degradation. To evaluate the importance of the integrity of the metal‐binding site on MCO, we subjected recombinant human growth hormone (rhGH), to MCO (ascorbate, Cu2+, 3O2) in the presence of various aliphatic alcohols (etha...
Saved in:
Published in | Journal of pharmaceutical sciences Vol. 90; no. 1; pp. 58 - 69 |
---|---|
Main Authors | , , , |
Format | Journal Article |
Language | English |
Published |
New York
Elsevier Inc
01.01.2001
John Wiley & Sons, Inc Wiley American Pharmaceutical Association |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Metal‐catalyzed oxidation (MCO) represents a prominent pathway of protein degradation. To evaluate the importance of the integrity of the metal‐binding site on MCO, we subjected recombinant human growth hormone (rhGH), to MCO (ascorbate, Cu2+, 3O2) in the presence of various aliphatic alcohols (ethanol, ethylene glycol, trifluoroethanol, 1‐propanol, 2‐propanol, 1,2‐propylene glycol, 1‐butanol, 2‐butanol, and tert‐butanol). All alcohols inhibited MCO in a concentration‐dependent and sigmoidal manner. Half‐points, P1/2, were dependent on the nature of the alcohol. Circular dichroism and fluorescence spectroscopy were used to monitor cosolvent‐induced secondary and tertiary structural changes. The presence of alcohols increased the helical content of rhGH and induced a red shift in the tryptophan emission. The midpoints of the tertiary structural change correlated with the P1/2 values. Solvent polarity at P1/2 was determined according to the ET(30) scale. All alcohol/water mixtures at P1/2 had rather similar solvent polarities between 54.5 to 56.4 kcal/mol, with the exception of ethylene glycol. On the other hand, no correlation was obtained between the protection against MCO and the hydroxyl radical‐scavenging properties of the cosolvent. We conclude that the primary mechanism of MCO inhibition is a cosolvent‐induced conformational perturbation of the metal‐binding site as opposed to pure radical scavenging. © 2001 Wiley‐Liss, Inc. and the American Pharmaceutical Association J Pharm Sci 90:58–69, 2001 |
---|---|
Bibliography: | ArticleID:JPS7 istex:F9ED408B756D9C1D218C9AFE37F41E2A4A578580 ark:/67375/WNG-Z63PW999-X ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ISSN: | 0022-3549 1520-6017 |
DOI: | 10.1002/1520-6017(200101)90:1<58::AID-JPS7>3.0.CO;2-W |